MicroTech Medical (Hangzhou) Co (HKSE:02235) Net Cash per Share : HK$4.64 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is MicroTech Medical (Hangzhou) Co Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). MicroTech Medical (Hangzhou) Co's Net Cash per Share for the quarter that ended in Dec. 2023 was HK$4.64.

The historical rank and industry rank for MicroTech Medical (Hangzhou) Co's Net Cash per Share or its related term are showing as below:

HKSE:02235' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 0.86 Med: 1.89 Max: 4.27
Current: 0.86

During the past 5 years, the highest Price-to-Net-Cash Ratio of MicroTech Medical (Hangzhou) Co was 4.27. The lowest was 0.86. And the median was 1.89.

HKSE:02235's Price-to-Net-Cash is ranked better than
94.94% of 316 companies
in the Medical Devices & Instruments industry
Industry Median: 6.93 vs HKSE:02235: 0.86

MicroTech Medical (Hangzhou) Co Net Cash per Share Historical Data

The historical data trend for MicroTech Medical (Hangzhou) Co's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroTech Medical (Hangzhou) Co Net Cash per Share Chart

MicroTech Medical (Hangzhou) Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Net Cash per Share

0.31

1.70

5.95

5.15

4.64

MicroTech Medical (Hangzhou) Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Cash per Share	Get a 7-Day Free Trial			5.95	5.58	5.15	5.09	4.64

Competitive Comparison of MicroTech Medical (Hangzhou) Co's Net Cash per Share

For the Medical Devices subindustry, MicroTech Medical (Hangzhou) Co's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MicroTech Medical (Hangzhou) Co's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroTech Medical (Hangzhou) Co's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where MicroTech Medical (Hangzhou) Co's Price-to-Net-Cash falls into.

MicroTech Medical (Hangzhou) Co Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

MicroTech Medical (Hangzhou) Co's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

	Net Cash per Share (A: Dec. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(2068.418	-	106.859	-	0)	/	422.439
=	4.64

MicroTech Medical (Hangzhou) Co's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

	Net Cash per Share (Q: Dec. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(2068.418	-	106.859	-	0)	/	422.439
=	4.64

MicroTech Medical (Hangzhou) Co (HKSE:02235) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.

MicroTech Medical (Hangzhou) Co Net Cash per Share Related Terms

Thank you for viewing the detailed overview of MicroTech Medical (Hangzhou) Co's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroTech Medical (Hangzhou) Co (HKSE:02235) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » Net Cash per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 108 Liuze Street, Cangqian Street, Yuhang District, Zhejiang Province, Hangzhou, CHN

Website

https://www.microtechmd.com

MicroTech Medical (Hangzhou) Co Ltd is engaged in the research and development and manufacturing and commercialization of diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve diabetes management in China and the rest of the world. The company derives a majority of its revenue from China.

Executives

Zheng Pan
Master Summer Limited	2201 Interest of corporation controlled by you
Cdbi Partners Gp, Ltd	2201 Interest of corporation controlled by you
Cdbi Partners Fund Ii, L.p.	2201 Interest of corporation controlled by you
Cdbi Partners Fund I, L.p.	2201 Interest of corporation controlled by you
Cdbi Gp, Ltd	2201 Interest of corporation controlled by you
Cd Capital Healthcare Fund V, L.p.	2201 Interest of corporation controlled by you
Cd Capital Gp Ltd	2201 Interest of corporation controlled by you
Zhe Jiang Jiu Ren Zi Ben Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Qiming Corporate Gp V, Ltd.	2201 Interest of corporation controlled by you
Qiming Gp V, L.p.	2201 Interest of corporation controlled by you
Qiming Venture Partners V, L.p.	2201 Interest of corporation controlled by you
Qm32 Limited	2101 Beneficial owner
Lav Asset Management (hong Kong) Limited	2102 Investment manager
Lav Evergreen (hong Kong) Co., Limited	2101 Beneficial owner

MicroTech Medical (Hangzhou) Co (HKSE:02235) Headlines

No Headlines